FDA approves first prescription-only app for depression
Related Articles
-
Stanford doctors help develop first FDA-approved gene-editing treatment
The FDA recently approved Casgevy, a gene-editing medical treatment which uses CRISPR/Cas9 technology to treat sickle cell disease. Casgevy, which two Stanford faculty members contributed to via drug development and FDA approval, is the first gene-editing medical treatment to recieve FDA approval.
-
SF ultrasound clinic using FDA-approved AI to help detect types of breast cancer faster
The typical breast screening age is 40 for mammography. Ultrasound screening is often preferred for younger patients, as it's free of radiation and there's no age restriction or doctor referral needed.
-
It's The First Drug Shown To Slow Alzheimer's. Why Is It Off To A Slow Start?
The first drug shown to slow Alzheimer’s disease hit the U.S. market over a year ago, but sales have lagged, major hospital systems have taken months to start using it and some insurers have rejected coverage.